Postmortem screening for fatty acid oxidation disorders by analysis of Guthrie cards with tandem mass spectrometry in sudden unexpected death in infancy

Journal of Pediatrics

Volumn 141, Issue 6, 2002, Pages 833-836

  Wilcox, Rebecca L ^a   Nelson, Cliff C ^a   Stenzel, Peter ^a   Steiner, Robert D ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCARNITINE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE;

ARTICLE; AUTOPSY; BLOOD LEVEL; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME DEFICIENCY; FATTY ACID OXIDATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; PRIORITY JOURNAL; SUDDEN INFANT DEATH SYNDROME; TANDEM MASS SPECTROMETRY;

EID: 0036907283     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.130259     Document Type: Article

References (14)

1. Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, et al. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers 418 cases of sudden death in the first year of life. J Pediatr 1998;132:924-33.
2. Bennett MJ, Powell S. Metabolic disease and sudden, unexpected death in infancy. Human Pathol 1994;25:742-6.
3. Lundemose JB, Kolvraa S, Gregersen N, Christensen E, Gregersen M. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infancy and young children: An investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years. Mol Pathol 1997;50:212-7.
4. Roe CR, Ding J. Mitochondrial fatty acid oxidation disorders. In: Scriver C, Beaudet A, Valle D, eds. The Metabolic & Molecular Bases of Inherited Disease. 8th Ed. New York: McGraw Hill; 2001. p. 2297-326.
5. Iafolla AK, Thompson Jr RJ, Roe CR. Medium-chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children. J Pediatr 1994;124:409-15.
6. Sluysmans T, Tuerlinckx D, Hubinont C, Verellen-Dumoulin C, Brivet M, Vianey-Saban C. Very long chain acylcoenzyme A dehydrogenase deficiency in two siblings: Evolution after prenatal diagnosis and prompt management. J Pediatr 1997;151:444-6.
7. Catzeflis C, Bachmann C, Hale DE, Coates PM, Wiesmann U, Colombo JP, et al. Early diagnosis and treatment of neonatal medium-chain acyl-CoA dehydrogenase deficiency: Report of two siblings. Eur J Pediatr 1990;149:577-81.
8. Oregon Department of Human Services and Health Division. Fetal and infant mortality. In: Oregon Vital Statistics Annual Report, 1996-2000. Vol I and II.
9. Bennett MJ, Spotswood SD, Ross KF, Comfort S, Koonce R, Boriack RL, et al. Fatal hepatic short-chain l-3-hydroxyacyl-coenzyme a dehydrogenase deficiency: Clinical, biochemical, and pathological studies on three subjects with this recently identified disorder of mitochondrial β-oxidation. Pediatr Dev Pathol 1999;2:337-45.
10. Boles RG, Martin SK, Blitzer MG, Rinaldo P. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver. Hum Pathol 1994;25:735-41.
11. Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, et al. Tandem mass spectrometry analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: A two-year summary from the New England Newborn Screening Program. Clin Chem 2001;47:1945-55.
12. Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001;47:1166-82.
13. Arens, R, Gozal D, Jain K, Muscati S, Heuser ET, Williams JC, et al. Prevalence of medium-chain acyl-coenzyme A dehydrogenase deficiency in the sudden infant death syndrome. J Pediatr 1993;122;715-8.
14. Charrow J, Goodman SI, McCabe ERG, Rinaldo P. Tandem mass spectrometry in newborn screening: American College of Medical Genetics Statement. Genet Med 2000;2:267-9.